These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18837857)

  • 1. Re: Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage.
    Nicklin J; Perrin L; Crandon A; Land R; Nascimento M; Obermair A
    Aust N Z J Obstet Gynaecol; 2008 Aug; 48(4):447. PubMed ID: 18837857
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant factor VIIa should be used in massive obstetric haemorrhage.
    Van de Velde M
    Int J Obstet Anesth; 2007 Oct; 16(4):357-9. PubMed ID: 17702565
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant factor VIIa should be used in massive obstetric haemorrhage.
    Plaat F
    Int J Obstet Anesth; 2007 Oct; 16(4):354-7. PubMed ID: 17698342
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant factor VIIa in massive obstetric haemorrhage.
    Bhuskute N; Kritzinger S; Dakin M
    Eur J Anaesthesiol; 2008 Mar; 25(3):250-1. PubMed ID: 18226279
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant factor VIIa in massive postpartum haemorrhage.
    Karalapillai D; Popham P
    Int J Obstet Anesth; 2007 Jan; 16(1):29-34. PubMed ID: 17125989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry.
    Phillips LE; McLintock C; Pollock W; Gatt S; Popham P; Jankelowitz G; Ogle R; Cameron PA;
    Anesth Analg; 2009 Dec; 109(6):1908-15. PubMed ID: 19923520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature.
    Boehlen F; Morales MA; Fontana P; Ricou B; Irion O; de Moerloose P
    BJOG; 2004 Mar; 111(3):284-7. PubMed ID: 14961895
    [No Abstract]   [Full Text] [Related]  

  • 8. Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage.
    Welsh A; McLintock C; Gatt S; Somerset D; Popham P; Ogle R
    Aust N Z J Obstet Gynaecol; 2008 Feb; 48(1):12-6. PubMed ID: 18275566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of recombinant activated factor VII in massive obstetric haemorrhage.
    Haynes J; Laffan M; Plaat F
    Int J Obstet Anesth; 2007 Jan; 16(1):40-9. PubMed ID: 17126006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful use of recombinant factor VIIa for treatment of severe postpartum hemorrhage.
    Hamaekers AE; van Mook WN; Offermans JP; Marcus MA
    Am J Crit Care; 2006 Jul; 15(4):399-401. PubMed ID: 16823017
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of recombinant activated factor VII in a case of severe postpartum haemorrhage.
    Verre M; Bossio F; Mammone A; Piccirillo M; Tancioni F; Varano M
    Minerva Ginecol; 2006 Feb; 58(1):81-4. PubMed ID: 16498374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of recombinant activated Factor VII in major obstetric haemorrhage: the Farnborough experience.
    Wissa I; Ebeid E; El-Shawarby S; Chandakas S; Kamal T; Hill N
    J Obstet Gynaecol; 2009 Jan; 29(1):21-4. PubMed ID: 19280490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recombinant factor VIIa for treatment of postpartum hemorrhage due to uterine atony].
    Michalska-Krzanowska G
    Ginekol Pol; 2010 Jul; 81(7):544-8. PubMed ID: 20825059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan.
    Kobayashi T; Nakabayashi M; Yoshioka A; Maeda M; Ikenoue T
    Int J Hematol; 2012 Jan; 95(1):57-63. PubMed ID: 22160834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
    Jirapinyo M; Manonai J; Herabutya Y; Chuncharunee S
    J Med Assoc Thai; 2007 May; 90(5):977-81. PubMed ID: 17596055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of recombinant factor VIIa for massive postpartum haemhorrage: case series and review of literature.
    Shamsi TS; Hossain N; Soomro N; Hasan JA; Noorani M; Kazi S; Quraishy MS; Jameel B; Sultan ST; Haider S
    J Pak Med Assoc; 2005 Nov; 55(11):512-5. PubMed ID: 16304877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant factor VIIa and other pro-haemostatic therapies in primary postpartum haemorrhage.
    Searle E; Pavord S; Alfirevic Z
    Best Pract Res Clin Obstet Gynaecol; 2008 Dec; 22(6):1075-88. PubMed ID: 18838340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for use of recombinant factor VIIa in life-threatening post-partum haemorrhage.
    Duffy MR
    Int J Obstet Anesth; 2007 Jul; 16(3):299-300; author reply 300. PubMed ID: 17509865
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of recombinant activated factor VII for massive postpartum hemorrhage.
    Hossain N; Shansi T; Haider S; Soomro N; Khan NH; Memon GU; Farzana T; Ansari S; Triche EW; Kuczynski E; Lockwood CJ; Paidas MJ
    Acta Obstet Gynecol Scand; 2007 Oct; 86(10):1200-6. PubMed ID: 17851797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa).
    Segal S; Shemesh IY; Blumenthal R; Yoffe B; Laufer N; Ezra Y; Levy I; Mazor M; Martinowitz U
    Arch Gynecol Obstet; 2003 Oct; 268(4):266-7. PubMed ID: 14504866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.